INDP

Indaptus Therapeutics develops cancer treatments using specially engineered viruses that target and destroy tumor cells. Doctors and hospitals would use these treatments for patients with certain types of cancer. The company makes money through research grants, partnerships with larger pharmaceutical companies, and potentially future drug sales if treatments get approved.